Postoperative inhaled nitric oxide after lung transplantation: A multicenter randomized clinical trial and exploratory analysis of treatment heterogeneity
Nitric Oxide · 2026
DOI: 10.1016/j.niox.2026.08.004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nitric Oxide, 2026. Verfasst von Shixiong Mai und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China. Hauptthemen laut MEDLINE: Lung Transplantation, Nitric Oxide, Primary Graft Dysfunction. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
BACKGROUND: The efficacy of prophylactic inhaled nitric oxide (iNO) in preventing primary graft dysfunction (PGD) after lung transplantation remains uncertain. We hypothesized that postoperative iNO would reduce the incidence of severe PGD. METHODS: In this multicenter, single-blind, randomized clinical trial conducted in China, adult lung transplant recipients were randomized (1:1) to receive iNO (10 ppm for 40 h followed by a protocolized taper to complete a planned 48-h course) or standard care. The primary outcome was PGD grade 2/3 at 48 h post-reperfusion. RESULTS: Of 86 randomized patients, 81 were evaluable (iNO, n = 40; Control, n = 41). The incidence of PGD grade 2/3 at 48 h did not differ significantly between groups (35.0% vs. 53.7%; risk ratio [RR], 0.65; 95% CI, 0.39-1.09; P = 0.09). No significant differences were found in secondary outcomes. In exploratory subgroup analyses, lower risk was observed among recipients with high intraoperative estimated blood loss (EBL ≥800 mL, P for interaction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
- The First Affiliated Hospital of the University of Science and Technology of China, Hefei, Anhui, 230001, China.
- Wuxi People's Hospital, Wuxi, Jiangsu, 214023, China.
- The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China; Key Laboratory of Early Warning and Intervention of Multiple Organ Failure, Hangzhou, Zhejiang, 310009, China. El…
- The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China; Wuxi People's Hospital, Wuxi, Jiangsu, 214023, China. Electronic address: chenjy@wuxiph.com.
Förderung
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Mai, S., Wan, H., Wu, J., Feng, M., Chang, S., Ke, L., Huang, J., Xu, H., Jiang, S., Wang, S., Lin, H., Chen, J., Zheng, X., Zhu, G., Ding, S., Teng, G., Ye, M., Huang, M., & Chen, J. (2026). Postoperative inhaled nitric oxide after lung transplantation: A multicenter randomized clinical trial and exploratory analysis of treatment heterogeneity. Nitric Oxide. https://doi.org/10.1016/j.niox.2026.08.004
Vancouver
Mai S, Wan H, Wu J, Feng M, Chang S, Ke L, et al. Postoperative inhaled nitric oxide after lung transplantation: A multicenter randomized clinical trial and exploratory analysis of treatment heterogeneity. Nitric Oxide. 2026. doi:10.1016/j.niox.2026.08.004
BibTeX
@article{Mai2026,
author = {Mai, Shixiong and Wan, Huqiang and Wu, Jing and Feng, Min and Chang, Siyuan and Ke, Li and Huang, Jian and Xu, Hongyang and Jiang, Shuyun and Wang, Song and Lin, Huiru and Chen, Juan and Zheng, Xiangxin and Zhu, Ganggui and Ding, Shuo and Teng, Gaoqin and Ye, Ming and Huang, Man and Chen, Jingyu},
title = {Postoperative inhaled nitric oxide after lung transplantation: A multicenter randomized clinical trial and exploratory analysis of treatment heterogeneity},
journal = {Nitric Oxide},
year = {2026},
doi = {10.1016/j.niox.2026.08.004}
}
EUVIMED